Baker Bros. Advisors — ABCL

How Baker Bros. Advisors's position in Abcellera Biologics Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held

2

First reported

Q4 2025

Latest value

$105,663,024

Latest weight

0.6%

Peak weight

0.6%

Shares since first

+10%

Position Trend

Shares, value, and weight from first report to latest report.

Baker Bros. Advisors first reported 27,525,640 shares in Q4 2025 and most recently reported 30,275,938 shares in Q1 2026. Portfolio weight peaked at 0.6% in Q1 2026; the low reported weight was 0.6% in Q4 2025.

Since the first report, shares are +10% and reported value is +12.2%. Latest move: ADD